Department of Periodontology, Institute of Dentistry, University of Turku, Turku, Finland.
The Forsyth Institute, Cambridge, Massachusetts, USA.
J Clin Periodontol. 2022 Jun;49(6):556-561. doi: 10.1111/jcpe.13617. Epub 2022 Apr 3.
The number of studies that aims to apply host- or microbe-derived biochemical biomarkers to periodontal disease diagnosis has increased significantly during the last three decades. The biochemical markers can reflect the presence, severity, and activity of periodontal diseases; however, heterogeneities in applied laboratory methods, data presentation, statistical analysis, and data interpretation prevent the translation of candidate host- or microbe-derived biochemical biomarkers to clinical assay validation. Here, we propose a roadmap for making the research outcomes comparable and re-analysable with the ultimate goal of translating research to clinical practice. This roadmap presents reporting recommendations for host- or microbe-derived biochemical biomarker studies in periodontology. We aim to make essential elements of the research work (including diagnostic criteria, clinical endpoint definitions, participant recruitment criteria, sample collection and storage techniques, biochemical and microbiological detection methods, and applied statistical analysis) visible and comparable.
在过去的三十年中,旨在将宿主或微生物来源的生化标志物应用于牙周病诊断的研究数量显著增加。生化标志物可以反映牙周病的存在、严重程度和活动情况;然而,应用的实验室方法、数据呈现、统计分析和数据解释的异质性阻碍了候选宿主或微生物来源的生化标志物向临床检测验证的转化。在这里,我们提出了一个路线图,以使研究结果具有可比性和可重新分析性,最终将研究转化为临床实践。该路线图提出了牙周病宿主或微生物来源生化标志物研究的报告建议。我们的目标是使研究工作的基本要素(包括诊断标准、临床终点定义、参与者招募标准、样本采集和储存技术、生化和微生物检测方法以及应用的统计分析)可见且具有可比性。